Physician

Chirag R Jani, MD

According to 2025 Medicare claims, Chirag Jani, MD (NPI: 1477525624) practices hematology/oncology in the Albany, GA market, with the plurality of this provider's patient population coming from Dougherty, GA. This provider's primary affiliated billing organization is PHOEBE PUTNEY MEMORIAL HOSPITAL INC (NPI: 1992789721; TIN: 581928247) and primary practice location at 31701-1975.

Jani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 681 traditional Medicare patients, billed 2,794 HCPCS/CPT codes, and received $168,794 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 4,183 prescription claims across 765 beneficiaries totaling $4,710,289 in drug costs, led by Xtandi (Enzalutamide). DME data shows 70 claims. Open Payments data shows 6 records totaling $598. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,332,629 to $4,710,289. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,656 and ending at $6,410.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	714	2,701	$138,000
2016	648	2,107	$95,128
2017	738	2,999	$141,235
2018	729	2,648	$124,508
2019	790	2,905	$150,674
2020	774	2,912	$156,335
2021	736	2,634	$156,287
2022	714	2,624	$156,948
2023	670	2,801	$169,197
2024	681	2,794	$168,794

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	473	2,942	$1,332,629
2016	503	3,225	$2,506,914
2017	517	3,114	$2,208,108
2018	543	3,374	$2,876,787
2019	598	3,827	$3,689,624
2020	633	4,044	$5,027,451
2021	634	3,757	$5,069,098
2022	657	3,600	$5,229,984
2023	698	3,798	$4,840,181
2024	765	4,183	$4,710,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	45	216	$97,807
2016	27	75	$5,709
2017	19	31	$9,474
2018	N/R	12	$216
2019	N/R	N/R	N/R
2020	N/R	34	$2,073
2021	N/R	13	$339
2022	N/R	38	$1,906
2023	N/R	40	$2,942
2024	N/R	70	$2,989

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	33	33	$137
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	82	82	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	417	1,297	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	509	1,081	$46
99441	Telephone medical discussion with physician, 5-10 minutes	64	67	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	53	1,590	$735,380
Calquence	Acalabrutinib Maleate	32	960	$491,776
Imbruvica	Ibrutinib	30	840	$474,387
Truqap	Capivasertib	14	392	$324,590
Lynparza	Olaparib	16	480	$274,046

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,802
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$545
K0001	Standard wheelchair	Y	N/R	12	$313
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$201
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	12	$128

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$98	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$500	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chirag R. Jani, MD?

Tedicare shows public-source Medicare data for Chirag R. Jani, MD (NPI 1477525624), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chirag R. Jani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chirag R. Jani, MD?

Chirag R. Jani, MD is linked to PHOEBE PUTNEY MEMORIAL HOSPITAL INC (billing NPI 1992789721) in the available physician profile data.

Does Chirag R. Jani, MD have Open Payments data?

Chirag R. Jani, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.